- | Country : -
- | organs : -
- | Specialty : -
Extract
Primary Objective: • To assess the efficacy, in term of PSA response rate, of multiple doses of CP 751,871 in combination with docetaxel and prednisone in patients with HRPC.
Inclusion criteria
- Metastatic hormone refractory (androgen indepedent) progressive prostate cancer (HRPC)